Abstract
A review of the pharmacokinetics of the highly active quinoline derivative, norfloxacin, is presented. The compound appears to be rapidly absorbed. The serum half-life is about 3.5 h and 30% of a given dose is recovered in the urine. Rapid penetration of an inflammatory exudate occurs. The compound is metabolized to a modest extent, probably in the liver, six metabolites being recogniied. The serum half-life is prolonged in severe renal impairment. Probenecid would appear to decrease the renal elimination. The possibility of treating both urinary and tissue infections with this compound is raised.

This publication has 0 references indexed in Scilit: